Bouffette, Selena;
Soret, Perrine;
Cole, Alice;
Nony, Emmanuel;
Barbier Saint Hilaire, Pierre;
Leclerc, Grégory;
Alaoui, Lamine;
... Denton, Christopher P; + view all
(2025)
Multi-omic analysis identifies biological processes underlying progressive interstitial lung disease in systemic sclerosis.
The FEBS Journal
10.1111/febs.70177.
(In press).
Preview |
Text
Denton_The FEBS Journal - 2025 - Bouffette - Multi‐omic analysis identifies biological processes underlying progressive.pdf Download (6MB) | Preview |
Abstract
Systemic sclerosis (SSc) is a rare autoimmune connective tissue disorder, and its primary cause of mortality is interstitial lung disease (ILD). This study aimed to identify markers in patients with SSc that are associated with ILD progression. In total, 52 SSc patients and five healthy volunteers (HVs) were included. Patient plasma samples were available for measurement of soluble mediators by metabolomics, proteomics, and cytokine quantification. Gene expression profiling was performed on patients' whole blood and skin biopsies, and immunophenotyping was carried out on peripheral blood mononuclear cells. Comparisons were made between patients with progressive ILD, those with no ILD, and HVs. Our results confirm the involvement of pro-inflammatory mechanisms in SSc-related ILD, with elevated type 1 interferon (IFN1), fractalkine (CX3CL1), and C-C motif chemokine 2 (CCL2), as well as the profibrotic markers C-X-C motif chemokine 17 (CXCL17), thrombospondin (THBS), and latent transforming growth factor beta-binding protein 1 (LTBP1). At the cellular level, lower inflammatory activity was observed in SSc-ILD patients, which may be due to ongoing immunosuppressive therapies. ILD progression is associated with a significant increase in plasma levels of cytoskeletal proteins and lipids, notably triglycerides. To our knowledge, this is the first study using an innovative approach to compare SSc patients with ILD to those without ILD. Our study was performed on well-characterized patients, from which we gathered insightful comparative data offering a multi-level biological picture of SSc-related ILD. A novel finding of our study is the correlation between elevated triglyceride levels and ILD progression, possibly linked to fibrogenesis through the role of triglycerides in endoplasmic reticulum stress.
| Type: | Article |
|---|---|
| Title: | Multi-omic analysis identifies biological processes underlying progressive interstitial lung disease in systemic sclerosis |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1111/febs.70177 |
| Publisher version: | https://doi.org/10.1111/febs.70177 |
| Language: | English |
| Additional information: | Copyright © 2025 The Author(s). The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. This is an open access article under the terms of the Creative Commons Attribution License, https://creativecommons.org/licenses/by/4.0/, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| Keywords: | Interstitial lung fibrosis; lung fibrosis; multiomics; scleroderma; systemic sclerosis |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10211043 |
Archive Staff Only
 |
View Item |
